Skip to main content
NovMetaPharma Co., Ltd. logo

NovMetaPharma Co., Ltd. — Investor Relations & Filings

Ticker · 229500 ISIN · KR7229500004 KO Manufacturing
Filings indexed 308 across all filing types
Latest filing 2025-02-05 Regulatory Filings
Country KR South Korea
Listing KO 229500

About NovMetaPharma Co., Ltd.

http://www.novmeta.com/

NovMetaPharma Co., Ltd. is a biopharmaceutical company specializing in the research and development of first-in-class drugs with differentiated mechanisms. The company focuses on creating novel therapeutics for metabolic and fibrotic diseases, addressing significant unmet medical needs. Its main pipeline includes drug candidates for type 2 diabetes (NovDB2), obesity (NovOB), chronic kidney disease (NovRD), and fibrosis (NovFS). The company's lead assets in clinical development are Cyclo-Z and CHP. NovMetaPharma aims to develop innovative treatments by leveraging its core research teams and efficient development systems to target the root causes of these complex conditions.

Recent filings

Filing Released Lang Actions
특허권취득(자율공시)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company NovMetaPharma. It details the patent name, content, and strategic use. Since this is a specific regulatory announcement regarding corporate activity that does not fit into financial reporting, dividend, or governance categories, it is classified as a general regulatory filing.
2025-02-05 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by NovMetaPharma. It outlines the date, time, participants, and agenda of the meeting. Since it is a regulatory announcement regarding the occurrence and outcome of an IR event rather than the presentation slides themselves, and it is a short regulatory filing, it falls under the category of general regulatory announcements.
2024-12-20 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent for a cell-protecting composition by NovMetaPharma. It details the patent name, content, and utilization plan. Since this is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting, governance, or shareholder meeting categories, it is classified as a general regulatory filing.
2024-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural step required for the meeting. Given it is a regulatory notification of a corporate event, it fits best under the RNS category.
2024-12-13 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure notice on the exchange.
2024-12-09 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party capital increase/private placement). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2024-11-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.